CATSPERG
gene geneOn this page
Also known as DKFZp434A1022FLJ46353
Summary
CATSPERG (catsper channel auxiliary subunit gamma, HGNC:25243) is a protein-coding gene on chromosome 19q13.2, encoding Cation channel sperm-associated auxiliary subunit gamma (Q6ZRH7). Auxiliary component of the CatSper complex, a complex involved in sperm cell hyperactivation.
CATSPERG is a subunit of the CATSPER (see CATSPER1; MIM 606389) sperm calcium channel, which is required for sperm hyperactivated motility and male fertility (Wang et al., 2009 [PubMed 19516020]).
Source: NCBI Gene 57828 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 188 total
- MANE Select transcript:
NM_021185
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25243 |
| Approved symbol | CATSPERG |
| Name | catsper channel auxiliary subunit gamma |
| Location | 19q13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DKFZp434A1022, FLJ46353 |
| Ensembl gene | ENSG00000099338 |
| Ensembl biotype | protein_coding |
| OMIM | 613452 |
| Entrez | 57828 |
Gene structure
Transcript identifiers
Ensembl transcripts: 16 — 6 retained_intron, 4 nonsense_mediated_decay, 4 protein_coding, 2 protein_coding_CDS_not_defined
ENST00000312265, ENST00000409235, ENST00000409410, ENST00000410018, ENST00000412458, ENST00000466060, ENST00000467739, ENST00000470292, ENST00000471517, ENST00000475343, ENST00000475646, ENST00000477793, ENST00000488473, ENST00000489693, ENST00000492088, ENST00000585424
RefSeq mRNA: 2 — MANE Select: NM_021185
NM_001330496, NM_021185
CCDS: CCDS12514, CCDS82346
Canonical transcript exons
ENST00000409235 — 29 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002238094 | 38352261 | 38352432 |
| ENSE00002784011 | 38337221 | 38337504 |
| ENSE00003461864 | 38362210 | 38362272 |
| ENSE00003473319 | 38364891 | 38364971 |
| ENSE00003480569 | 38367509 | 38367572 |
| ENSE00003499487 | 38359470 | 38359581 |
| ENSE00003501343 | 38354710 | 38354847 |
| ENSE00003532967 | 38344296 | 38344368 |
| ENSE00003535751 | 38367156 | 38367312 |
| ENSE00003536133 | 38365061 | 38365117 |
| ENSE00003537580 | 38362714 | 38362832 |
| ENSE00003538986 | 38361648 | 38361861 |
| ENSE00003553834 | 38362376 | 38362574 |
| ENSE00003581960 | 38356484 | 38356543 |
| ENSE00003585663 | 38369972 | 38370064 |
| ENSE00003588692 | 38356742 | 38356861 |
| ENSE00003589313 | 38367681 | 38367776 |
| ENSE00003592439 | 38358432 | 38358561 |
| ENSE00003598303 | 38358278 | 38358328 |
| ENSE00003619754 | 38360731 | 38360843 |
| ENSE00003631144 | 38360489 | 38360647 |
| ENSE00003631329 | 38346450 | 38346605 |
| ENSE00003654975 | 38370526 | 38370943 |
| ENSE00003661445 | 38370159 | 38370258 |
| ENSE00003665020 | 38337593 | 38337646 |
| ENSE00003670613 | 38343580 | 38343724 |
| ENSE00003676776 | 38368048 | 38368137 |
| ENSE00003677548 | 38343993 | 38344119 |
| ENSE00003847996 | 38335830 | 38335875 |
Expression profiles
Bgee: expression breadth ubiquitous, 168 present calls, max score 96.48.
FANTOM5 (CAGE): breadth broad, TPM avg 2.1658 / max 217.0966, expressed in 723 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 175616 | 1.4094 | 592 |
| 175618 | 0.4236 | 159 |
| 175615 | 0.1929 | 54 |
| 175614 | 0.0792 | 30 |
| 175617 | 0.0607 | 31 |
Top tissues by expression
278 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 96.48 | gold quality |
| right testis | UBERON:0004534 | 96.26 | gold quality |
| sperm | CL:0000019 | 92.62 | gold quality |
| testis | UBERON:0000473 | 92.62 | gold quality |
| male germ cell | CL:0000015 | 90.38 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 84.93 | gold quality |
| cerebellar cortex | UBERON:0002129 | 84.40 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 84.38 | gold quality |
| sural nerve | UBERON:0015488 | 82.72 | gold quality |
| cerebellum | UBERON:0002037 | 82.07 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 79.94 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 77.89 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 76.75 | silver quality |
| granulocyte | CL:0000094 | 76.61 | gold quality |
| cortical plate | UBERON:0005343 | 76.41 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 75.92 | gold quality |
| monocyte | CL:0000576 | 75.15 | gold quality |
| leukocyte | CL:0000738 | 75.00 | gold quality |
| mononuclear cell | CL:0000842 | 74.91 | gold quality |
| thyroid gland | UBERON:0002046 | 74.61 | gold quality |
| skin of leg | UBERON:0001511 | 74.26 | gold quality |
| skin of abdomen | UBERON:0001416 | 73.85 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 73.12 | gold quality |
| colonic epithelium | UBERON:0000397 | 72.85 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 72.41 | gold quality |
| ganglionic eminence | UBERON:0004023 | 71.83 | gold quality |
| endocervix | UBERON:0000458 | 71.70 | gold quality |
| ascending aorta | UBERON:0001496 | 71.05 | gold quality |
| apex of heart | UBERON:0002098 | 71.02 | gold quality |
| thoracic aorta | UBERON:0001515 | 70.97 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-70580 | yes | 51.74 |
| E-ANND-3 | yes | 5.64 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
22 targeting CATSPERG, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6758-5P | 100.00 | 66.21 | 1470 |
| HSA-MIR-6856-5P | 100.00 | 65.47 | 1298 |
| HSA-MIR-30A-5P | 100.00 | 76.31 | 3233 |
| HSA-MIR-30B-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30C-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30D-5P | 100.00 | 76.32 | 3233 |
| HSA-MIR-30E-5P | 100.00 | 76.32 | 3242 |
| HSA-MIR-7152-3P | 99.97 | 67.47 | 849 |
| HSA-MIR-10527-5P | 99.91 | 72.28 | 3754 |
| HSA-MIR-4492 | 99.87 | 68.25 | 3611 |
| HSA-MIR-4645-3P | 99.76 | 69.33 | 993 |
| HSA-MIR-762 | 99.58 | 66.61 | 1994 |
| HSA-MIR-4498 | 99.47 | 67.42 | 2360 |
| HSA-MIR-12113 | 99.32 | 67.54 | 1072 |
| HSA-MIR-4505 | 99.27 | 67.81 | 2678 |
| HSA-MIR-5001-5P | 99.05 | 66.76 | 1972 |
| HSA-MIR-548AO-5P | 98.55 | 69.57 | 1362 |
| HSA-MIR-548AX | 98.55 | 69.58 | 1362 |
| HSA-MIR-6776-5P | 98.54 | 67.43 | 1304 |
| HSA-MIR-8081 | 96.42 | 67.75 | 738 |
| HSA-MIR-627-5P | 95.51 | 66.80 | 509 |
| HSA-MIR-2861 | 95.24 | 65.47 | 1056 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Catsperg2 | ENSMUSG00000049123 |
| mus_musculus | Catsperg1 | ENSMUSG00000049676 |
| rattus_norvegicus | Catsperg | ENSRNOG00000060693 |
Protein
Protein identifiers
Cation channel sperm-associated auxiliary subunit gamma — Q6ZRH7 (reviewed: Q6ZRH7)
All UniProt accessions (8): Q6ZRH7, B8ZZI7, F8WDD6, H9KV36, K7EQR6, K7EQY4, M0QZ16, X1WI24
UniProt curated annotations — full annotation on UniProt →
Function. Auxiliary component of the CatSper complex, a complex involved in sperm cell hyperactivation. Sperm cell hyperactivation is needed for sperm motility which is essential late in the preparation of sperm for fertilization.
Subunit / interactions. Component of the CatSper complex or CatSpermasome composed of the core pore-forming members CATSPER1, CATSPER2, CATSPER3 and CATSPER4 as well as auxiliary members CATSPERB, CATSPERG, CATSPERD, CATSPERE, CATSPERZ, CATSPERT, CATSPERQ, CATSPERH and EFCAB9. HSPA1 may be an additional auxiliary complex member. The core complex members CATSPER1, CATSPER2, CATSPER3 and CATSPER4 form a heterotetrameric channel. The auxiliary CATSPERB, CATSPERG, CATSPERD and CATSPERE subunits form a pavilion-like structure over the pore which stabilizes the complex through interactions with CATSPER4, CATSPER3, CATSPER1 and CATSPER2 respectively. CATSPERH interacts with CATSPERB, further stabilizing the complex. CATSPERT interacts at least with CATSPERD and is required for targeting the CatSper complex in the flagellar membrane.
Subcellular location. Cell projection. Cilium. Flagellum membrane.
Similarity. Belongs to the CATSPERG family.
RefSeq proteins (2): NP_001317425, NP_067008* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR028246 | CATSPERG | Family |
| IPR053871 | CATSPERG_beta-prop | Domain |
| IPR053872 | CATSPERG_N | Domain |
| IPR053873 | CATSPERG_C | Domain |
| IPR053874 | CATSPERG_Ig-like | Domain |
Pfam: PF15064, PF22840, PF22846, PF22851
UniProt features (25 total): disulfide bond 9, glycosylation site 4, sequence variant 3, topological domain 2, sequence conflict 2, signal peptide 1, chain 1, transmembrane region 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6ZRH7-F1 | 83.99 | 0.50 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (9): 44–105, 159–165, 288–343, 394–402, 638–860, 806–834, 882–1046, 909–918, 1010–1016
Glycosylation sites (4): 574, 102, 355, 426
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-1300642 | Sperm Motility And Taxes |
MSigDB gene sets: 92 (showing top):
GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_UP, GSE18804_SPLEEN_MACROPHAGE_VS_COLON_TUMORAL_MACROPHAGE_UP, GOBP_MALE_GAMETE_GENERATION, GOBP_SPERM_CAPACITATION, GOBP_ANATOMICAL_STRUCTURE_MATURATION, GOBP_CELL_MATURATION, GOBP_CILIUM_MOVEMENT, GOBP_CILIUM_OR_FLAGELLUM_DEPENDENT_CELL_MOTILITY, GOBP_CELLULAR_PROCESS_INVOLVED_IN_REPRODUCTION_IN_MULTICELLULAR_ORGANISM, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, GOCC_VOLTAGE_GATED_CALCIUM_CHANNEL_COMPLEX, GOCC_MOTILE_CILIUM, GOCC_CATION_CHANNEL_COMPLEX, GOCC_SPERM_PRINCIPAL_PIECE, GOCC_TRANSPORTER_COMPLEX
GO Biological Process (2): spermatogenesis (GO:0007283), cell differentiation (GO:0030154)
GO Molecular Function (0):
GO Cellular Component (7): plasma membrane (GO:0005886), motile cilium (GO:0031514), CatSper complex (GO:0036128), sperm principal piece (GO:0097228), cilium (GO:0005929), membrane (GO:0016020), cell projection (GO:0042995)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Fertilization | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| developmental process involved in reproduction | 1 |
| male gamete generation | 1 |
| cellular developmental process | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cilium | 1 |
| voltage-gated calcium channel complex | 1 |
| sperm flagellum | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
Protein interactions and networks
STRING
732 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CATSPERG | CATSPER1 | Q8NEC5 | 972 |
| CATSPERG | CATSPERB | Q9H7T0 | 847 |
| CATSPERG | CATSPERD | Q86XM0 | 806 |
| CATSPERG | CATSPERE | Q5SY80 | 627 |
| CATSPERG | TSACC | Q96A04 | 587 |
| CATSPERG | CYLC2 | Q14093 | 565 |
| CATSPERG | CATSPER3 | Q86XQ3 | 548 |
| CATSPERG | CATSPER2 | Q96P56 | 545 |
| CATSPERG | CATSPER4 | Q7RTX7 | 538 |
| CATSPERG | ANKZF1 | Q9H8Y5 | 474 |
| CATSPERG | SPATA16 | Q9BXB7 | 472 |
| CATSPERG | CATSPERZ | Q9NTU4 | 432 |
| CATSPERG | TXNDC8 | Q6A555 | 420 |
| CATSPERG | CLEC4A | Q9UMR7 | 418 |
| CATSPERG | WFIKKN1 | Q96NZ8 | 410 |
IntAct
0 interactions, top by confidence:
BioGRID (5): CATSPERG (Affinity Capture-RNA), CATSPERG (Affinity Capture-RNA), CATSPERG (Affinity Capture-MS), CATSPERG (Affinity Capture-MS), CATSPERG (Two-hybrid)
ESM2 similar proteins: A0A0A6YXX9, A0A1Z2R986, A2RTF1, C6KI89, E9Q355, F5HFJ7, O36400, P03425, P04853, P09258, P09728, P0DP43, P12554, P12556, P16772, P19758, P21526, P22229, P28907, P35740, P35771, Q04547, Q2TAV2, Q2YDM0, Q3TBN1, Q499E0, Q4R6B2, Q5BKX0, Q5E9L2, Q5RDR5, Q66000, Q66001, Q68FB2, Q6AY76, Q6DFY8, Q6ZRH7, Q76B58, Q77MP7, Q77NN4, Q783Y1
Diamond homologs: C6KI89, E9Q355, Q4R6B2, Q6ZRH7
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| CATSPERG | “form complex” | “CatSpermasome complex” | binding |
Disease & clinical
Clinical variants and AI predictions
ClinVar
188 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 159 |
| Likely benign | 12 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
5491 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:38344366:G:GT | donor_gain | 1.0000 |
| 19:38358420:T:A | acceptor_gain | 1.0000 |
| 19:38358425:C:CA | acceptor_gain | 1.0000 |
| 19:38358426:G:A | acceptor_gain | 1.0000 |
| 19:38358427:GTCAG:G | acceptor_loss | 1.0000 |
| 19:38358430:A:AG | acceptor_gain | 1.0000 |
| 19:38358430:A:T | acceptor_loss | 1.0000 |
| 19:38358431:G:GA | acceptor_gain | 1.0000 |
| 19:38358513:ACCC:A | donor_gain | 1.0000 |
| 19:38358557:CAGAG:C | donor_loss | 1.0000 |
| 19:38358558:AGAGG:A | donor_loss | 1.0000 |
| 19:38358559:GAG:G | donor_gain | 1.0000 |
| 19:38358560:AGG:A | donor_loss | 1.0000 |
| 19:38358561:GG:G | donor_loss | 1.0000 |
| 19:38359468:A:AG | acceptor_gain | 1.0000 |
| 19:38359469:G:GA | acceptor_gain | 1.0000 |
| 19:38359469:GCTCT:G | acceptor_gain | 1.0000 |
| 19:38359579:G:GT | donor_gain | 1.0000 |
| 19:38360727:GCA:G | acceptor_loss | 1.0000 |
| 19:38360729:A:AG | acceptor_gain | 1.0000 |
| 19:38360729:AGCT:A | acceptor_gain | 1.0000 |
| 19:38360729:AGCTG:A | acceptor_gain | 1.0000 |
| 19:38360730:G:A | acceptor_loss | 1.0000 |
| 19:38360730:G:GA | acceptor_gain | 1.0000 |
| 19:38360730:GC:G | acceptor_gain | 1.0000 |
| 19:38360730:GCT:G | acceptor_gain | 1.0000 |
| 19:38360730:GCTG:G | acceptor_gain | 1.0000 |
| 19:38360730:GCTGG:G | acceptor_gain | 1.0000 |
| 19:38360842:GG:G | donor_gain | 1.0000 |
| 19:38360842:GGGT:G | donor_loss | 1.0000 |
AlphaMissense
7692 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:38369973:T:A | W1008R | 0.999 |
| 19:38369973:T:C | W1008R | 0.999 |
| 19:38352364:G:C | R310P | 0.998 |
| 19:38368064:T:A | W983R | 0.998 |
| 19:38368064:T:C | W983R | 0.998 |
| 19:38369975:G:C | W1008C | 0.998 |
| 19:38369975:G:T | W1008C | 0.998 |
| 19:38367267:T:A | C909S | 0.997 |
| 19:38367267:T:C | C909R | 0.997 |
| 19:38367268:G:C | C909S | 0.997 |
| 19:38367294:T:C | C918R | 0.997 |
| 19:38367296:C:G | C918W | 0.997 |
| 19:38368066:G:C | W983C | 0.997 |
| 19:38368066:G:T | W983C | 0.997 |
| 19:38352281:G:C | W282C | 0.996 |
| 19:38352281:G:T | W282C | 0.996 |
| 19:38358543:G:T | G493V | 0.996 |
| 19:38367268:G:A | C909Y | 0.996 |
| 19:38367269:C:G | C909W | 0.996 |
| 19:38367295:G:A | C918Y | 0.996 |
| 19:38369997:T:C | C1016R | 0.996 |
| 19:38337370:T:A | W46R | 0.995 |
| 19:38337370:T:C | W46R | 0.995 |
| 19:38337372:G:C | W46C | 0.995 |
| 19:38337372:G:T | W46C | 0.995 |
| 19:38354715:T:A | W335R | 0.995 |
| 19:38354715:T:C | W335R | 0.995 |
| 19:38367202:G:C | R887P | 0.995 |
| 19:38367294:T:A | C918S | 0.995 |
| 19:38367295:G:C | C918S | 0.995 |
dbSNP variants (sampled 300 via entrez): RS1000060846 (19:38352453 C>A), RS1000138922 (19:38340897 G>C,T), RS1000171924 (19:38355368 A>C), RS1000203160 (19:38355779 C>T), RS1000409973 (19:38361470 G>A), RS1000493332 (19:38365042 C>T), RS1000505936 (19:38348636 G>C), RS1000558233 (19:38348289 G>A), RS1000602309 (19:38338118 G>A), RS1000685282 (19:38349926 A>G), RS1000702775 (19:38336694 A>C,G), RS1000753708 (19:38336502 C>G), RS1000937974 (19:38360774 G>A), RS1001029932 (19:38341927 A>C), RS1001067964 (19:38371041 T>C)
Disease associations
OMIM: gene MIM:613452 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST012139_5 | D-dimer levels in HIV infection | 4.000000e-12 |
| GCST90002395_410 | Mean platelet volume | 3.000000e-18 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004507 | D dimer measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
31 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, decreases expression, increases methylation | 4 |
| bisphenol A | decreases expression, increases methylation | 2 |
| 2,4,6-tribromophenol | decreases expression | 1 |
| decabromobiphenyl ether | decreases expression | 1 |
| tris(2-butoxyethyl) phosphate | affects expression | 1 |
| sodium arsenite | decreases expression | 1 |
| butyraldehyde | increases expression | 1 |
| tetrabromobisphenol A | decreases expression | 1 |
| perfluorooctanoic acid | increases expression | 1 |
| benzo(e)pyrene | decreases methylation | 1 |
| aflatoxin B2 | decreases methylation | 1 |
| perfluoro-n-nonanoic acid | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| perfluorohexanesulfonic acid | increases expression | 1 |
| abrine | increases expression | 1 |
| 2,2’,4,4’-tetrabromodiphenyl ether | decreases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| pentabrominated diphenyl ether 100 | decreases expression | 1 |
| hexabrominated diphenyl ether 153 | decreases expression | 1 |
| licochalcone B | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Benzo(a)pyrene | decreases expression | 1 |
| Doxorubicin | increases expression | 1 |
| Estradiol | decreases expression | 1 |
| Methapyrilene | decreases methylation | 1 |
| Smoke | decreases expression | 1 |
| Toluene | decreases methylation, increases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Okadaic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.